Emcure Pharmaceuticals disclosed postal ballot results under Regulation 44(3) of SEBI LODR, with three special resolutions passed effective March 20, 2026.
All three resolutions re-appointing independent directors — Gokhale, Yeravdekar, and Ayyangar — were approved with requisite three-fourths majority.
Overall voter participation was ~82% of total outstanding shares (155.5 million of 189.6 million shares polled across resolutions).
Resolution 2 (Yeravdekar re-appointment) saw notable institutional opposition with 77.73% of institutional votes cast against it, though it passed overall.